Drug Type ASO |
Synonyms- |
Target |
Mechanism UNC13A modulators(unc-13 homolog A modulators), RNA interference |
Active Indication |
Inactive Indication- |
Originator Organization Acurastem, Inc.Startup |
Active Organization Acurastem, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | US | Acurastem, Inc.Startup | 30 Mar 2023 |
Frontotemporal Dementia | Preclinical | US | Acurastem, Inc.Startup | 30 Mar 2023 |